The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
- PMID: 32778421
- PMCID: PMC7402212
- DOI: 10.1016/j.jiph.2020.07.011
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
Abstract
There is currently an ongoing worldwide pandemic of a novel virus belonging to the family of Coronaviruses (CoVs) which are large, enveloped, plus-stranded RNA viruses. Coronaviruses belong to the order of Nidovirales, family of Coronavirinae and are divided into four genera: alphacoronavirus, betacoronavirus, gammacoronavirus and deltacoronavirus. CoVs cause diseases in a wide variety of birds and mammals and have been found in humans since 1960. To date, seven human CoVs were identified including the alpha-CoVs HCoVs-NL63 and HCoVs-229E and the beta-CoVs HCoVs-OC43, HCoVs-HKU1, the severe acute respiratory syndrome-CoV (SARS-CoV), the Middle East respiratory syndrome-CoV (MERS-CoV) and the novel virus that first appeared in December 2019 in Wuhan, China, and rapidly spread to 213 countries as of the writing this paper. It was officially named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the international committee on taxonomy of viruses (ICTV) and the disease's name is COVID-19 for coronavirus disease 2019. SARS-CoV-2 is very contagious and is capable of spreading from human to human. Infection routes include droplet and contact, and aerosol transmission is currently under investigation. It is associated with a respiratory illness that may cause severe pneumonia and acute respiratory distress syndrome (ARDS). SARS-CoV-2 became an emergency of international concern. As of July 12, 2020, the virus has been responsible for 12,698,995 confirmed cases and 564,924 deaths worldwide and the number is still increasing. Up until now, no specific treatment has yet been proven effective against SARS-CoV-2. Since the beginning of this outbreak, several interesting papers on SARS-CoV-2 and COVID-19 have been published to report on the phylogenetic evolution, epidemiology, pathogenesis, transmission as well as clinical characteristics of COVID-19 and possible treatments agents. This paper is a systematic review of the available literature on SARS-CoV-2. It was performed in accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and aims to help readers access the latest knowledge surrounding this new infectious disease and to provide a reference for future studies.
Keywords: COVID-19; Emergence; Prevention; SARS-CoV-2; Transmission; Treatment.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
None declared.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7402212/bin/gr1_lrg.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7402212/bin/gr2_lrg.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7402212/bin/gr3_lrg.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7402212/bin/gr4_lrg.gif)
Comment in
-
Mortality from COVID-19: are we getting closer to the true value?Pathog Glob Health. 2020 Oct;114(7):347-348. doi: 10.1080/20477724.2020.1827617. Epub 2020 Oct 4. Pathog Glob Health. 2020. PMID: 33012277 Free PMC article. No abstract available.
Similar articles
-
The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.Int J Environ Res Public Health. 2020 Aug 5;17(16):5648. doi: 10.3390/ijerph17165648. Int J Environ Res Public Health. 2020. PMID: 32764417 Free PMC article. Review.
-
Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.Infez Med. 2020 Jun 1;28(suppl 1):6-17. Infez Med. 2020. PMID: 32532933 Review.
-
Properties of Coronavirus and SARS-CoV-2.Malays J Pathol. 2020 Apr;42(1):3-11. Malays J Pathol. 2020. PMID: 32342926 Review.
-
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.Pediatr Infect Dis J. 2020 May;39(5):355-368. doi: 10.1097/INF.0000000000002660. Pediatr Infect Dis J. 2020. PMID: 32310621 Free PMC article. Review.
-
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0. Mil Med Res. 2020. PMID: 32169119 Free PMC article. Review.
Cited by
-
Coronavirus disease-2019 and orthopedics: A bibliometric analysis of the literature.Medicine (Baltimore). 2024 Apr 12;103(15):e37714. doi: 10.1097/MD.0000000000037714. Medicine (Baltimore). 2024. PMID: 38608113 Free PMC article.
-
Treatment and Rehabilitation of a Patient with Neuromyelitis Optica Spectrum Disorder-Induced Complete Spinal Cord Injury Following COVID-19 Vaccination: A Case Report.J Clin Med. 2024 Feb 19;13(4):1175. doi: 10.3390/jcm13041175. J Clin Med. 2024. PMID: 38398485 Free PMC article.
-
COVID-19 and Alzheimer's Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future.Cells. 2023 Nov 10;12(22):2601. doi: 10.3390/cells12222601. Cells. 2023. PMID: 37998336 Free PMC article. Review.
-
Using Scientific Articles on COVID-19 to Introduce the Nature of Scientific Knowledge to Medical Students.Med Sci Educ. 2023 Aug 24;33(5):1247-1251. doi: 10.1007/s40670-023-01874-0. eCollection 2023 Oct. Med Sci Educ. 2023. PMID: 37886272 Free PMC article.
-
Point-of-Care Devices for Viral Detection: COVID-19 Pandemic and Beyond.Micromachines (Basel). 2023 Sep 7;14(9):1744. doi: 10.3390/mi14091744. Micromachines (Basel). 2023. PMID: 37763907 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous